Previous 10 | Next 10 |
BOCA RATON, Fla. , Sept. 28, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the shipment of an...
BOCA RATON, Fla, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces its participation in...
2023-08-08 09:22:10 ET Medical device company, Sensus Healthcare ( NASDAQ: SRTS ) Board of Directors has authorized a new share repurchase program under which the company may repurchase up to $3M of its common stock. Joe Sardano, chairman and CEO comments, “We will ...
BOCA RATON, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its Board of Dire...
2023-08-06 06:14:02 ET Sensus Healthcare, Inc (SRTS) Q2 2023 Earnings Conference Call August 03, 2023, 04:30 PM ET Company Participants Kim Golodetz - IR Joseph Sardano - Chairman and CEO Michael Sardano - President and General Counsel Javier Rampolla - CFO ...
2023-08-03 17:00:26 ET Sensus Healthcare press release ( NASDAQ: SRTS ): Q2 GAAP EPS of -$0.02 beats by $0.06 . Revenue of $4.5M (-62.8% Y/Y) misses by $0.05M . Cash and cash equivalents were $20.1 million as of June 30, 2023, compared with $25.5 million as of ...
Revenues increased 33% and system shipments increased 30%, both compared with the first quarter of 2023 Achieved a milestone with the installation of 700 systems for a total of 708 Expects to ship at least 60 SRT units during 2023 and to return to profitability in the seco...
2023-07-31 01:41:02 ET Summary Sensus Healthcare's stock has been highly sensitive to its earnings reports, with consistent sell-offs following each less-than-stellar quarterly earnings release. Sensus has recently shifted into negative operational cash flow, and its lack of recur...
BOCA RATON, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on ...
Delivery of the SRT-100 marks the expansion of radiotherapy services at Dublin’s Beacon Hospital Non-melanoma skin cancer affects more than 12,000 patients in Ireland annually BOCA RATON, Fla., July 25, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ...
News, Short Squeeze, Breakout and More Instantly...
Sensus Healthcare Inc. Company Name:
SRTS Stock Symbol:
NASDAQ Market:
Sensus Healthcare Inc. Website:
2024-05-17 09:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Novavax Inc. (NVAX) rose 98.7% to $8.88 on volume of 168,692,127 shares AEye Inc. (LIDR) rose 115.0% to $2.58 on volume of 156,236,079 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 17.3% to $0.7609 on volume of 123,678,040 s...
Revenues of $10.7 million, compared with $3.4 million in the prior-year quarter; A djusted EBITDA (a non-GAAP measure) of $3.0 million, compared with negative $2.7 million in the prior-year quarter Launched the “Fair Deal Agreement” recurring revenue program to pro...